{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:25:12Z","timestamp":1793834712475,"version":"4.6.1"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1053\/j.gastro.2026.08.017","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:04:40Z","timestamp":1788167080000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of Obesity: Review of Adjunctive Therapies and Clinical Management Pearls"],"prefix":"10.1053","author":[{"given":"Shelby","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Tavakkoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Scott","family":"Butsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2026.08.017_bib1","article-title":"Obesity and severe obesity prevalence in adults: United States, August 2021\u2013August 2023","author":"Emmerich","year":"2024","journal-title":"National Health and Nutrition Examination Survey"},{"key":"10.1053\/j.gastro.2026.08.017_bib2","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.2018.13022","article-title":"Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force Recommendation Statement","volume":"320","year":"2018","journal-title":"JAMA"},{"issue":"Suppl 2","key":"10.1053\/j.gastro.2026.08.017_bib3","first-page":"S102","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2026.08.017_bib4","first-page":"S167","article-title":"8. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes\u20132025","volume":"48","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2026.08.017_bib5","doi-asserted-by":"crossref","first-page":"e875","DOI":"10.1503\/cmaj.191707","article-title":"Obesity in adults: a clinical practice guideline","volume":"192","author":"Wharton","year":"2020","journal-title":"CMAJ"},{"key":"10.1053\/j.gastro.2026.08.017_bib6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cgh.2016.10.023","article-title":"White paper AGA: POWER - practice guide on obesity and weight management, education, and resources","volume":"15","author":"Acosta","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.08.017_bib7","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/oby.2011.230","article-title":"Four-year weight losses in the Look AHEAD study: factors associated with long-term success","volume":"19","author":"Wadden","year":"2011","journal-title":"Obesity (Silver Spring, Md)"},{"key":"10.1053\/j.gastro.2026.08.017_bib8","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study","volume":"374","year":"2009","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2026.08.017_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2026.08.017_bib10","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/oby.20309","article-title":"A randomized, phase 3 trial of naltrexone SR\/bupropion SR on weight and obesity-related risk factors (COR-II)","volume":"21","author":"Apovian","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1053\/j.gastro.2026.08.017_bib11","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJMoa2500969","article-title":"Oral semaglutide at a dose of 25 mg in adults with overweight or obesity","volume":"393","author":"Wharton","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2026.08.017_bib12","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1056\/NEJMoa2511774","article-title":"Orforglipron, an oral small-molecule GLP-1 receptor agonist for obesity treatment","volume":"393","author":"Wharton","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2026.08.017_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.27.1.155","article-title":"XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients","volume":"27","author":"Torgerson","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2026.08.017_bib14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/oby.22430","article-title":"Safety and effectiveness of longer-term phentermine use: clinical outcomes from an electronic health record cohort","volume":"27","author":"Lewis","year":"2019","journal-title":"Obesity (Silver Spring)"},{"key":"10.1053\/j.gastro.2026.08.017_bib15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/oby.2011.330","article-title":"Controlled-release phentermine\/topiramate in severely obese adults: a randomized controlled trial (EQUIP)","volume":"20","author":"Allison","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1053\/j.gastro.2026.08.017_bib16","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2026.08.017_bib17","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S2213-8587(25)00226-8","article-title":"Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial","volume":"13","author":"Wharton","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1053\/j.gastro.2026.08.017_bib18","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2213-8587(20)30364-8","article-title":"Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials","volume":"8","author":"Clement","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1053\/j.gastro.2026.08.017_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2026.08.017_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3945\/ajcn.111.024927","article-title":"Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study","volume":"95","author":"Garvey","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.gastro.2026.08.017_bib21","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2026.08.017_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/oby.2008.461","article-title":"Rational design of a combination medication for the treatment of obesity","volume":"17","author":"Greenway","year":"2009","journal-title":"Obesity (Silver Spring)"},{"issue":"Suppl 4","key":"10.1053\/j.gastro.2026.08.017_bib23","first-page":"66","article-title":"Bupropion sustained release and smoking cessation","volume":"59","author":"Goldstein","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1053\/j.gastro.2026.08.017_bib24","doi-asserted-by":"crossref","first-page":"532","DOI":"10.7326\/0003-4819-142-7-200504050-00012","article-title":"Meta-analysis: pharmacologic treatment of obesity","volume":"142","author":"Li","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2026.08.017_bib25","first-page":"347","article-title":"A controlled trial of naltrexone in obese humans","volume":"9","author":"Malcolm","year":"1985","journal-title":"Int J Obes"},{"key":"10.1053\/j.gastro.2026.08.017_bib26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(10)60888-4","article-title":"Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"376","author":"Greenway","year":"2010","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2026.08.017_bib27","article-title":"Department of Health and Human Services. NDA approval","year":"2014","journal-title":"Saxenda (liraglutide [rDNA origin])"},{"key":"10.1053\/j.gastro.2026.08.017_bib28","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.2337\/db17-0058","article-title":"Mechanisms controlling glucose-induced GLP-1 secretion in human small intestine","volume":"66","author":"Sun","year":"2017","journal-title":"Diabetes"},{"key":"10.1053\/j.gastro.2026.08.017_bib29","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1172\/JCI78371","article-title":"Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight","volume":"124","author":"Baggio","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1053\/j.gastro.2026.08.017_bib30","doi-asserted-by":"crossref","first-page":"R885","DOI":"10.1152\/ajpregu.00520.2015","article-title":"GLP-1 and weight loss: unraveling the diverse neural circuitry","volume":"310","author":"Kanoski","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1053\/j.gastro.2026.08.017_bib31","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.3390\/nu15224809","article-title":"What is food noise? A conceptual model of food cue reactivity","volume":"15","author":"Hayashi","year":"2023","journal-title":"Nutrients"},{"key":"10.1053\/j.gastro.2026.08.017_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2026.08.017_bib33","article-title":"OR11-01 Efficacy and safety of setmelanotide in acquired hypothalamic obesity: results from a double-blind, multicenter, placebo-controlled, randomized phase 3 trial","volume":"9","author":"Phillips","year":"2025","journal-title":"J Endocr Soc"},{"key":"10.1053\/j.gastro.2026.08.017_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.ijo.0803695","article-title":"Metformin and body weight","volume":"32","author":"Golay","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"10.1053\/j.gastro.2026.08.017_bib35","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2337\/dc20-1473","article-title":"Efficacy and safety of dulaglutide 3.0 mg and 4.5 mg versus dulaglutide 1.5 mg in metformin-treated patients with type 2 diabetes in a randomized controlled trial (AWARD-11)","volume":"44","author":"Frias","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2026.08.017_bib36","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2337\/dc08-0029","article-title":"Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity","volume":"31","author":"Smith","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2026.08.017_bib37","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1111\/j.1467-789X.2010.00846.x","article-title":"Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials","volume":"12","author":"Kramer","year":"2011","journal-title":"Obes Rev"},{"key":"10.1053\/j.gastro.2026.08.017_bib38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eplepsyres.2011.05.014","article-title":"Topiramate-induced weight loss: a review","volume":"95","author":"Verrotti","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1053\/j.gastro.2026.08.017_bib39","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/2013.jamainternmed.99","article-title":"Zonisamide for weight reduction in obese adults: a 1-year randomized controlled trial","volume":"172","author":"Gadde","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2026.08.017_bib40","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/oby.2002.86","article-title":"Bupropion SR enhances weight loss: a 48-week double-blind, placebo-controlled trial","volume":"10","author":"Anderson","year":"2002","journal-title":"Obes Res"},{"key":"10.1053\/j.gastro.2026.08.017_bib41","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1038\/oby.2009.478","article-title":"Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial","volume":"18","author":"Aronne","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1053\/j.gastro.2026.08.017_bib42","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.4088\/JCP.v68n0809","article-title":"Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study","volume":"68","author":"Gadde","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1053\/j.gastro.2026.08.017_bib43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.ijo.0803382","article-title":"Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study","volume":"31","author":"Toplak","year":"2007","journal-title":"Int J Obes (Lond)"},{"key":"10.1053\/j.gastro.2026.08.017_bib44","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2026.08.017_bib45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2026.08.017_bib46","first-page":"2398","article-title":"Semaglutide and heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"Reply. N Engl J Med"},{"key":"10.1053\/j.gastro.2026.08.017_bib47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2026.08.017_bib48","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2026.08.017_bib49","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.tem.2020.02.006","article-title":"How may GIP enhance the therapeutic efficacy of GLP-1?","volume":"31","author":"Samms","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"10.1053\/j.gastro.2026.08.017_bib50","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.2337\/db21-0459","article-title":"GIP receptor agonism attenuates GLP-1 Receptor agonist-induced nausea and emesis in preclinical models","volume":"70","author":"Borner","year":"2021","journal-title":"Diabetes"},{"key":"10.1053\/j.gastro.2026.08.017_bib51","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2026.08.017_bib52","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2026.08.017_bib53","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/oby.24331","article-title":"Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status","volume":"33","author":"Gasoyan","year":"2025","journal-title":"Obesity (Silver Spring)"},{"key":"10.1053\/j.gastro.2026.08.017_bib54","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple-hormone-receptor agonist retatrutide for obesity - a phase 2 trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2026.08.017_bib56","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa2401755","article-title":"A phase 2 randomized trial of survodutide in MASH and fibrosis","volume":"391","author":"Sanyal","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2026.08.017_bib57","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2026.08.017_bib58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.2023.24945","article-title":"Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial","volume":"331","author":"Aronne","year":"2024","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2026.08.017_bib59","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/oby.23120","article-title":"Selection of antiobesity medications based on phenotypes enhances weight loss: a pragmatic trial in an obesity clinic","volume":"29","author":"Acosta","year":"2021","journal-title":"Obesity (Silver Spring)"},{"key":"10.1053\/j.gastro.2026.08.017_bib60","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.cmet.2025.05.008","article-title":"Genetic and physiological insights into satiation variability predict responses to obesity treatment","volume":"37","author":"Cifuentes","year":"2025","journal-title":"Cell Metab"},{"key":"10.1053\/j.gastro.2026.08.017_bib61","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.mcna.2021.06.005","article-title":"Treating the chronic disease of obesity","volume":"105","author":"Gossmann","year":"2021","journal-title":"Med Clin North Am"},{"key":"10.1053\/j.gastro.2026.08.017_bib62","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1002\/oby.21629","article-title":"Early weight loss with liraglutide 3.0 mg predicts 1-year weight loss and is associated with improvements in clinical markers","volume":"24","author":"Fujioka","year":"2016","journal-title":"Obesity (Silver Spring)"},{"issue":"9","key":"10.1053\/j.gastro.2026.08.017_bib63","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/ijo.2016.67","article-title":"The relationship between early weight loss and weight loss at 1 year with naltrexone ER\/bupropion ER combination therapy","volume":"40","author":"Fujioka","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"10.1053\/j.gastro.2026.08.017_bib64","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/oby.21555","article-title":"Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy: results of a prospective study","volume":"24","author":"G\u00f3mez","year":"2016","journal-title":"Obesity"},{"key":"10.1053\/j.gastro.2026.08.017_bib65","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.gie.2023.12.004","article-title":"American Society for Gastrointestinal Endoscopy-European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity","volume":"99","author":"Jirapinyo","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2026.08.017_bib66","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1053\/j.gastro.2021.03.003","article-title":"AGA clinical practice guidelines on intragastric balloons in the management of obesity","volume":"160","author":"Muniraj","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.08.017_bib67","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1053\/j.gastro.2021.02.043","article-title":"AGA technical review on intragastric balloons in the management of obesity","volume":"160","author":"Shah","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.08.017_bib68","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.soard.2018.12.007","article-title":"Clinical safety and effectiveness of a swallowable gas-filled intragastric balloon system for weight loss: consecutively treated patients in the initial year of US commercialization","volume":"15","author":"Moore","year":"2019","journal-title":"Surg Obes Relat Dis"},{"key":"10.1053\/j.gastro.2026.08.017_bib69","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cgh.2018.01.046","article-title":"Single fluid-filled intragastric balloon safe and effective for inducing weight loss in a real-world population","volume":"16","author":"Vargas","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.08.017_bib70","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.soard.2018.09.486","article-title":"Randomized sham-controlled trial of the 6-month swallowable gas-filled intragastric balloon system for weight loss","volume":"14","author":"Sullivan","year":"2018","journal-title":"Surg Obes Relat Dis"},{"key":"10.1053\/j.gastro.2026.08.017_bib71","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ijo.2016.229","article-title":"Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial","volume":"41","author":"Courcoulas","year":"2017","journal-title":"Int J Obes (Lond)"},{"key":"10.1053\/j.gastro.2026.08.017_bib72","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s11695-020-05084-0","article-title":"Efficacy and safety of intragastric balloon (IGB) in non-alcoholic fatty liver disease (NAFLD): a comprehensive review and meta-analysis","volume":"31","author":"Chandan","year":"2021","journal-title":"Obes Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib73","doi-asserted-by":"crossref","first-page":"815","DOI":"10.4254\/wjh.v13.i7.815","article-title":"Effects of intragastric balloon placement in metabolic dysfunction-associated fatty liver disease: a systematic review and meta-analysis","volume":"13","author":"de Freitas J\u00fanior","year":"2021","journal-title":"World J Hepatol"},{"key":"10.1053\/j.gastro.2026.08.017_bib74","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ajg.2016.530","article-title":"The impact of intragastric balloons on obesity-related co-morbidities: a systematic review and meta-analysis","volume":"112","author":"Popov","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.08.017_bib75","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cgh.2020.04.068","article-title":"Intragastric balloon placement induces significant metabolic and histologic improvement in patients with nonalcoholic steatohepatitis","volume":"19","author":"Bazerbachi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.08.017_bib76","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s11695-022-06437-7","article-title":"Intragastric balloon significantly improves metabolic parameters at 6 months: a meta-analysis","volume":"33","author":"Shah","year":"2023","journal-title":"Obes Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib78","series-title":"Orbera intragastric balloon system [physician brochure]. Boston Scientific","year":"2024"},{"key":"10.1053\/j.gastro.2026.08.017_bib79","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.gie.2015.03.1964","article-title":"ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies","volume":"82","author":"Abu Dayyeh","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2026.08.017_bib80","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s11695-015-1863-8","article-title":"Gastrointestinal physiological changes and their relationship to weight loss following the POSE procedure","volume":"26","author":"Espin\u00f3s","year":"2016","journal-title":"Obes Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib81","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/gutjnl-2022-327816","article-title":"Effect of endoscopic sleeve gastroplasty on gastric emptying, motility and hormones: a comparative prospective study","volume":"72","author":"Vargas","year":"2023","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.08.017_bib82","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.gie.2022.07.017","article-title":"Comparison of endoscopic sleeve gastroplasty versus surgical sleeve gastrectomy: a Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database analysis","volume":"97","author":"Gudur","year":"2023","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2026.08.017_bib83","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0140-6736(22)01280-6","article-title":"Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial","volume":"400","author":"Abu Dayyeh","year":"2022","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2026.08.017_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2023.04.094","article-title":"Weight-loss and metabolic outcomes of endoscopic sleeve gastroplasty (ESG) in the clinical setting","volume":"97","author":"Al Annan","year":"2023","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2026.08.017_bib85","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cgh.2016.12.012","article-title":"Endoscopic sleeve gastroplasty significantly reduces body mass index and metabolic complications in obese patients","volume":"15","author":"Sharaiha","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.08.017_bib86","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.gie.2022.04.1346","article-title":"Comparison of distal primary obesity surgery endolumenal techniques for the treatment of obesity (with videos)","volume":"96","author":"Jirapinyo","year":"2022","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2026.08.017_bib87","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cgh.2022.04.019","article-title":"Prospective multicenter study of the primary obesity surgery endoluminal (POSE 2.0) procedure for treatment of obesity","volume":"21","author":"Lopez Nava","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.08.017_bib88","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.gie.2020.08.023","article-title":"Improvement in insulin resistance and estimated hepatic steatosis and fibrosis after endoscopic sleeve gastroplasty","volume":"93","author":"Hajifathalian","year":"2021","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2026.08.017_bib89","doi-asserted-by":"crossref","first-page":"983","DOI":"10.14309\/ajg.0000000000002087","article-title":"Regression of hepatic fibrosis after endoscopic gastric plication in nonalcoholic fatty liver disease","volume":"118","author":"Jirapinyo","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.08.017_bib90","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.cgh.2020.09.055","article-title":"Five-year outcomes of endoscopic sleeve gastroplasty for the treatment of obesity","volume":"19","author":"Sharaiha","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl","key":"10.1053\/j.gastro.2026.08.017_bib91","doi-asserted-by":"crossref","first-page":"S1473","DOI":"10.14309\/01.ajg.0001037620.30740.d4","article-title":"Ten-year outcomes of endoscopic sleeve gastroplasty for the treatment of obesity","volume":"119","author":"Lahooti","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.08.017_bib92","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000647","article-title":"Performance of endoscopic sleeve gastroplasty by obesity class in the united states clinical setting","volume":"15","author":"Gala","year":"2024","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1053\/j.gastro.2026.08.017_bib93","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s42255-021-00458-9","article-title":"Diet-induced alteration of intestinal stem cell function underlies obesity and prediabetes in mice","volume":"3","author":"Aliluev","year":"2021","journal-title":"Nat Metab"},{"key":"10.1053\/j.gastro.2026.08.017_bib94","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eprac.2022.10.177","article-title":"Duodenal mucosa: a new target for the treatment of type 2 diabetes","volume":"29","author":"Nie","year":"2023","journal-title":"Endocr Pract"},{"key":"10.1053\/j.gastro.2026.08.017_bib95","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1210\/jc.2010-1333","article-title":"Small intestinal alterations in severely obese hyperglycemic subjects","volume":"96","author":"Verdam","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.gastro.2026.08.017_bib96","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/oby.23653","article-title":"Obesity and overweight are linked to increased sodium-glucose cotransporter 1 and glucose transporter 5 levels in duodenum","volume":"31","author":"Fiorentino","year":"2023","journal-title":"Obesity (Silver Spring)"},{"key":"10.1053\/j.gastro.2026.08.017_bib98","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2337\/dc17-1985","article-title":"Effect of the duodenal-jejunal bypass liner on glycemic control in patients with type 2 diabetes with obesity: a meta-analysis with secondary analysis on weight loss and hormonal changes","volume":"41","author":"Jirapinyo","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2026.08.017_bib99","doi-asserted-by":"crossref","first-page":"AB10","DOI":"10.1016\/j.gie.2022.04.076","article-title":"A multicenter randomized sham-controlled trial of a duodenal jejunal bypass liner for the treatment of type 2 diabetes mellitus","volume":"95","author":"Thompson","year":"2022","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2026.08.017_bib100","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.2337\/dc16-0383","article-title":"Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study","volume":"39","author":"Rajagopalan","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2026.08.017_bib101","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.gie.2024.04.2904","article-title":"Recellularization via electroporation therapy of the duodenum combined with glucagon-like peptide-1 receptor agonist to replace insulin therapy in patients with type 2 diabetes: 12-month results of a first-in-human study","volume":"100","author":"Busch","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2026.08.017_bib102","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.igie.2025.03.008","article-title":"Radiofrequency vapor ablation for duodenal mucosal ablation in the treatment of type 2 diabetes: results from the first-in-human pilot study","volume":"4","author":"Norton","year":"2025","journal-title":"iGIE"},{"key":"10.1053\/j.gastro.2026.08.017_bib103","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.gie.2024.01.031","article-title":"Insulin sensitivity and beta cell function after duodenal mucosal resurfacing: an open-label, mechanistic, pilot study","volume":"100","author":"Busch","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2026.08.017_bib104","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/gutjnl-2020-323608","article-title":"Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial","volume":"71","author":"Mingrone","year":"2022","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.08.017_bib105","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s11695-020-05170-3","article-title":"Metabolic effects of endoscopic duodenal mucosal resurfacing: a systematic review and meta-analysis","volume":"31","author":"de Oliveira","year":"2021","journal-title":"Obes Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib106","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.eprac.2025.07.017","article-title":"American Association of Clinical Endocrinology consensus statement: algorithm for the evaluation and treatment of adults with obesity\/adiposity-based chronic disease \u2013 2025 update","volume":"31","author":"Nadolsky","year":"2025","journal-title":"Endocr Pract"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2026.08.017_bib107","first-page":"S166","article-title":"8. Obesity and weight management for the prevention and treatment of diabetes: standards of care in diabetes\u20132026","volume":"49","year":"2025","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2026.08.017_bib108","first-page":"S145","article-title":"8. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2026.08.017_bib109","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.soard.2022.08.013","article-title":"2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): indications for metabolic and bariatric surgery","volume":"18","author":"Eisenberg","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"10.1053\/j.gastro.2026.08.017_bib110","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.soard.2016.05.018","article-title":"Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by International Diabetes Organizations","volume":"12","author":"Rubino","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"10.1053\/j.gastro.2026.08.017_bib111","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa2002449","article-title":"Life expectancy after bariatric surgery in the Swedish Obese Subjects Study","volume":"383","author":"Carlsson","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2026.08.017_bib112","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/oby.23646","article-title":"Long-term all-cause and cause-specific mortality for four bariatric surgery procedures","volume":"31","author":"Adams","year":"2023","journal-title":"Obesity (Silver Spring)"},{"key":"10.1053\/j.gastro.2026.08.017_bib114","series-title":"Laparoscopic gastric band placement","author":"Seeras","year":"2025"},{"key":"10.1053\/j.gastro.2026.08.017_bib115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11695-007-9312-y","article-title":"The impact of Roux limb length on weight loss after gastric bypass","volume":"18","author":"Ciovica","year":"2008","journal-title":"Obes Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib116","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.soard.2018.10.010","article-title":"A long biliopancreatic and short alimentary limb results in more weight loss in revisional RYGB surgery. Outcomes of the randomized controlled ELEGANCE REDO trial","volume":"15","author":"Boerboom","year":"2019","journal-title":"Surg Obes Relat Dis"},{"key":"10.1053\/j.gastro.2026.08.017_bib117","doi-asserted-by":"crossref","first-page":"741","DOI":"10.7326\/M17-2786","article-title":"Comparative effectiveness and safety of bariatric procedures for weight loss: a PCORnet cohort study","volume":"169","author":"Arterburn","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2026.08.017_bib118","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijsu.2009.11.004","article-title":"Outcomes of sleeve gastrectomy for morbid obesity: a safe and effective procedure?","volume":"8","author":"Armstrong","year":"2010","journal-title":"Int J Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib119","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4293\/108680812X13517013317077","article-title":"Sleeve gastrectomy as a stand-alone bariatric operation for severe, morbid, and super obesity","volume":"17","author":"Eisenberg","year":"2013","journal-title":"JSLS"},{"key":"10.1053\/j.gastro.2026.08.017_bib120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.soard.2017.11.021","article-title":"Midterm outcomes of laparoscopic sleeve gastrectomy as a stand-alone procedure in super-obese patients","volume":"14","author":"Hong","year":"2018","journal-title":"Surg Obes Relat Dis"},{"key":"10.1053\/j.gastro.2026.08.017_bib121","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamasurg.2013.3654","article-title":"The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012","volume":"149","author":"Chang","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib122","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s11695-013-1047-3","article-title":"The effects of bougie caliber on leaks and excess weight loss following laparoscopic sleeve gastrectomy. Is there an ideal bougie size?","volume":"23","author":"Yuval","year":"2013","journal-title":"Obes Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib123","series-title":"Sleeve gastrectomy","author":"Seeras","year":"2025"},{"key":"10.1053\/j.gastro.2026.08.017_bib124","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1007\/s11695-022-06254-y","article-title":"Comparative effectiveness and safety between endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy: a meta-analysis of 6775 individuals with obesity","volume":"32","author":"Beran","year":"2022","journal-title":"Obes Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib125","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/jamasurg.2022.2229","article-title":"Effect of laparoscopic sleeve gastrectomy vs Roux-en-y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: the SLEEVEPASS randomized clinical trial","volume":"157","author":"Salminen","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib126","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.0087","article-title":"Comparing the 5-year diabetes outcomes of sleeve gastrectomy and gastric bypass: the national Patient-Centered Clinical Research Network (PCORNet) bariatric study","volume":"155","author":"McTigue","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib127","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11695-016-2235-8","article-title":"Long-term results of laparoscopic sleeve gastrectomy for morbid obesity: 5 to 8-year results","volume":"27","author":"Gadiot","year":"2017","journal-title":"Obes Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib128","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.soard.2016.10.006","article-title":"Long-term results after sleeve gastrectomy: a systematic review","volume":"13","author":"Juodeikis","year":"2017","journal-title":"Surg Obes Relat Dis"},{"key":"10.1053\/j.gastro.2026.08.017_bib129","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.soard.2022.06.284","article-title":"American Society for Metabolic and Bariatric Surgery 2020 estimate of metabolic and bariatric procedures performed in the United States","volume":"18","author":"Clapp","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"10.1053\/j.gastro.2026.08.017_bib130","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/bjs\/znab245","article-title":"Perioperative mortality in bariatric surgery: meta-analysis","volume":"108","author":"Robertson","year":"2021","journal-title":"Br J Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib131","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jamasurg.2019.5470","article-title":"Interventions and operations 5 years after bariatric surgery in a cohort from the US National Patient-Centered Clinical Research Network Bariatric Study","volume":"155","author":"Courcoulas","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib132","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jamasurg.2024.7052","article-title":"Long-term outcomes of laparoscopic Roux-en-y gastric bypass vs laparoscopic sleeve gastrectomy for obesity: the SM-BOSS randomized clinical trial","volume":"160","author":"Kraljevic","year":"2025","journal-title":"JAMA Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib133","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.soard.2021.03.007","article-title":"ASMBS position statement on the rationale for performance of upper gastrointestinal endoscopy before and after metabolic and bariatric surgery","volume":"17","author":"Campos","year":"2021","journal-title":"Surg Obes Relat Dis"},{"key":"10.1053\/j.gastro.2026.08.017_bib134","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jama.2019.14231","article-title":"Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity","volume":"322","author":"Aminian","year":"2019","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2026.08.017_bib135","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.soard.2019.04.004","article-title":"Comparison of early type 2 diabetes improvement after gastric bypass and sleeve gastrectomy: medication cessation at discharge predicts 1-year outcomes","volume":"15","author":"Heshmati","year":"2019","journal-title":"Surg Obes Relat Dis"},{"key":"10.1053\/j.gastro.2026.08.017_bib136","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.suc.2020.12.006","article-title":"Physiologic mechanisms of weight loss following metabolic\/bariatric surgery","volume":"101","author":"Luo","year":"2021","journal-title":"Surg Clin North Am"},{"key":"10.1053\/j.gastro.2026.08.017_bib137","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/oby.23647","article-title":"Identifying barriers to shared decision-making about bariatric surgery in two large health systems","volume":"31","author":"Arterburn","year":"2023","journal-title":"Obesity (Silver Spring)"},{"key":"10.1053\/j.gastro.2026.08.017_bib138","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.14340","article-title":"Ten-year outcomes following Roux-en-y gastric bypass vs duodenal switch for high body mass index: a randomized clinical trial","volume":"7","author":"Salte","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1053\/j.gastro.2026.08.017_bib139","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1007\/s11695-024-07490-0","article-title":"Single anastomosis duodeno-ileostomy with sleeve gastrectomy\/single anastomosis duodenal switch (SADI-S\/SADS) IFSO position statement-update 2023","volume":"34","author":"Ponce de Leon-Ballesteros","year":"2024","journal-title":"Obes Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib140","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-8587(24)00035-4","article-title":"Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass at 5 years (YOMEGA): a prospective, open-label, non-inferiority, randomised extension study","volume":"12","author":"Robert","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1053\/j.gastro.2026.08.017_bib141","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11695-024-07181-w","article-title":"Utilization of anti-obesity medications after bariatric surgery: analysis of a large national database","volume":"34","author":"Firkins","year":"2024","journal-title":"Obes Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib142","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamasurg.2023.2930","article-title":"Safety and efficacy of liraglutide, 3.0 mg, once daily vs placebo in patients with poor weight loss following metabolic surgery: the BARI-OPTIMISE randomized clinical trial","volume":"158","author":"Mok","year":"2023","journal-title":"JAMA Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib143","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1097\/JS9.0000000000000990","article-title":"Boosting weight loss after conversional Roux-en-Y gastric bypass with liraglutide and placebo use. A double-blind-randomized controlled trial","volume":"110","author":"Hany","year":"2024","journal-title":"Int J Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib144","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.soard.2024.08.037","article-title":"A randomized, double-blind, placebo-controlled trial of weight loss using liraglutide 3.0 mg for weight recurrence after Roux-en-Y gastric bypass","volume":"21","author":"Lofton","year":"2025","journal-title":"Surg Obes Relat Dis"},{"key":"10.1053\/j.gastro.2026.08.017_bib145","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-8587(19)30157-3","article-title":"Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"Miras","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1053\/j.gastro.2026.08.017_bib146","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11695-011-0514-y","article-title":"Intragastric balloon in association with lifestyle and\/or pharmacotherapy in the long-term management of obesity","volume":"22","author":"Farina","year":"2012","journal-title":"Obes Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib147","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11695-023-06975-8","article-title":"Effect of swallow balloon therapy with the combination of semaglutide oral formulation: a randomised double-blind single-centre study","volume":"34","author":"Mathur","year":"2024","journal-title":"Obes Surg"},{"key":"10.1053\/j.gastro.2026.08.017_bib148","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.gie.2020.10.016","article-title":"Endoscopic sleeve gastroplasty plus liraglutide versus endoscopic sleeve gastroplasty alone for weight loss","volume":"93","author":"Badurdeen","year":"2021","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2026.08.017_bib149","doi-asserted-by":"crossref","first-page":"e1458","DOI":"10.1055\/a-2463-9784","article-title":"Efficacy of anti-obesity medication (AOM) and endoscopic gastric remodeling (EGR): analysis of combination therapy with optimal timing and agents","volume":"12","author":"Jirapinyo","year":"2024","journal-title":"Endosc Int Open"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508526071842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508526071842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:46:10Z","timestamp":1793832370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508526071842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":145,"alternative-id":["S0016508526071842"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2026.08.017","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Obesity: Review of Adjunctive Therapies and Clinical Management Pearls","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2026.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}]}}